期刊文献+

武汉市大学生精神疾病临床调查及预防干预 被引量:3

Clinic Survey and Prevention Intervention for College Students with Mental Disorders,Wuhan
下载PDF
导出
摘要 目的:调查武汉大学生精神疾病患者,为高校精神疾病预防干预提供科学依据。方法:对197例大学生精神疾病患者住院记录进行档案研究,并对其中15名住院患者进行深度访谈。结果:武汉大学生精神疾病高发年龄是20-21岁,男性多于女性;精神疾病类型以情感类障碍为主,抑郁症和精神分裂症最为常见;平均病程为65天。大学生精神疾病是多种因素迭加产生的结果,深度访谈从生理、社会、心理、应激、适应功能和风险性6个方面描述了大学生精神疾病的高危特征。结论:高校应重视精神卫生服务,整合个体与社区水平形成系统的预防干预。 Objective: The paper aimed at providing evidence for college crisis intervention through clinic investigations. Methods: 197 hospital records of college students with mental disorders in Wuhan were used in document research, and 15 patients among them were invited to interview one-to-one. Results: There are three distinguishing features among those clients: the age of onset was 20-21 at most, men's incident rate were more than women's; emotional disorders were most popular among college students, and depress disorder and schizophrenia were at the top of disorders; average of courses were 65 days. According to interview research, multiple factors resulted in college students of mental disorders, which high risk traits are described at six dimensionality including physiological, social, psychological, stress, school adjustment and risk factors. Conclusion: Scientific and systemic preventive intervention programs are recommended to develop in all colleges, and individual-level interventions should be integrated with community-level interventions basing on local characteristics.
出处 《医学与社会》 2012年第9期75-78,共4页 Medicine and Society
基金 湖北省人文社科项目 编号为2008z017
关键词 精神疾病 预防干预 大学生 Mental disorders Preventive intervention College students
  • 相关文献

参考文献13

  • 1林崇德.积极而科学地开展心理健康教育[J].北京师范大学学报(社会科学版),2003(1):31-37. 被引量:168
  • 2Trull T J,Phares EJ.临床心理学-概念、方法和职业[M].第6版.北京:中国轻工业出版社,2005.
  • 3潘令仪,王祖承.自杀的国内研究概况[J].中国行为医学科学,2005,14(7):669-670. 被引量:39
  • 4Lafolleffe A. The Evolution of University Counseling: From Educational Guidance to Multicultural Competence, Severe Mental Illnesses and Crisis Planning[J]. Graduate Journal of Counseling Psychology, 2009, 1 (2) : 112-120.
  • 5Canadian Mental Health Association. Mental Health Promotion for People With Mental Illness [EB/OL]. (2005- 08-18).http ://www.phac-aspc.gc.ca/publicat/mh-sm/mhp02 -psm02/index-eng.php.
  • 6Selman R L,Dray A J.儿童心理学手册(卷四):应用儿童心理学[M].上海:华东师范大学出版社,2009.
  • 7李广泽,汤宜朗,蔡焯基,马胜民.116例住院高校生精神障碍患者的临床特点分析[J].中国心理卫生杂志,2003,17(12):851-851. 被引量:3
  • 8张维熙,李淑然,陈昌惠,黄悦勤,王金荣,王德平,涂健,宁佐喜,付力牧,纪丽萍,刘志广,吴化民,罗开林,翟书涛,严和,孟国荣.中国七个地区精神疾病流行病学调查[J].中华精神科杂志,1998,31(2):69-71. 被引量:342
  • 9Phillips M R, Zhang J,Shi Q,et al. Prevalence, Treatment, and Associated Disability" of Mental Disorders in Four Provinces in China During 2001-2005 :an Epidemiological Survey[J]. Lancet,2009(373) : 2041-2053.
  • 10刘薇薇,徐玉敏,裴怡,肖秀兰.北医大学生因精神疾病休退学情况调查报告[J].中国学校卫生,1997,18(2):146-147. 被引量:12

二级参考文献33

共引文献564

同被引文献34

  • 1傅伟忠.4007名大中学生心理卫生知识知晓率的现状调查[J].上海精神医学,2005,17(B09):12-13. 被引量:24
  • 2EMSLEY R, OOSTHUIZEN P, KOEN L, et al. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone longacting injection [J]. Int Clin Psychopharmacol, 2008 , 23 (6): 325-331.
  • 3NUSSBAUM AM, STROUP T S. Paliperidone palmitate for schizophrenia [J]. Cochrane Library ,2012,3 (6) :69-72.
  • 4LIEBERMAN J A, STROUP T S, MCEUOY J P, et al. Eff- ectiveness of antipsychotic drugs in patients with chronic schizophrenia [J]. N Engl J Med, 2005 , 353 ( 12) : 1209 - 1223.
  • 5MCEVOY J P, LIEBERMAN J A, PERKINS D 0, et al. Efficacy and tolerability of olanzapine , quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison [J]. Am J Psychiatry ,2007,164(7) : 1050-1060.
  • 6SABATE E. Adherence to long-term therapies: evidence for action [Z]. Geneva, Switzerland: W orId Health Organization, 2003.
  • 7NEWTON R,HUSTIG H,LAKSHMANA R,et al. Practical guidelines on the use of paliperidone palmitate in schizophrenia[J] . CUff Med Res Opin , 2012,28 ( 4) : 559- 567.
  • 8CHUE P, CHUE J. A review of paliperidone palmitate [J] . Expert Rev. Neurother,2012,12(12) :1383-1397.
  • 9PEUSKENS J, RUBIO G, SCHREINER A. Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice [J]. Ann Gen Psychiatry ,2014,13 (1) : 10.
  • 10LEUCHT C,HERES S,KANE J M,et al. Oral versus depot antipsychotic dTIlgs for schizophrenia-a critical systematic review and meta-analysis of randomised long-term trials[J]. Schizophr Res,2011 ,127( 1-3) :83-92.

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部